Evaluating Efficacy and Safety of Oral Melatonin in Acute Central Serous Chorioretinopathy

In this group, participants will be randomly assigned to take 3 mg tablets of melatonin twice a day for 1 month.

The placebo is also prepared in the form of tablets with similar packaging as melatonin by the pharmaceutical company. Participants will be randomly assigned to take placebo with the same frequency and duration as melatonin (twice a day for 1 month).